Unicare Biomedical, Inc. – Trademark Portfolio

Entity Type: 03

Unicare Biomedical, Inc. holds 17 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 12 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 8 trademarks are registered and 1 is pending. Notable registered marks include REVOSS, BENACEL, CURAGEN, CYTOFLEX, and COLLAFLEX. The owner is based in Laguna Hills, CA.

25951 La Cuesta Avenue

Laguna Hills, CA 92653

17 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Unicare Biomedical, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (12 filings)

Surgical, medical, dental and veterinary apparatus and instruments

5
Pharmaceuticals (6 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Unicare Biomedical, Inc. have?

Unicare Biomedical, Inc. has 17 U.S. trademarks filed with the USPTO. Of these, 8 registered, 1 pending, 5 abandoned, 3 cancelled.

What trademark classes does Unicare Biomedical, Inc. file in?

Unicare Biomedical, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Unicare Biomedical, Inc.'s most well-known trademarks?

Unicare Biomedical, Inc.'s registered trademark portfolio includes well-known marks such as REVOSS, BENACEL, CURAGEN, CYTOFLEX, and COLLAFLEX. These are among 8 currently registered trademarks in the portfolio.

What is Unicare Biomedical, Inc.'s trademark registration success rate?

Unicare Biomedical, Inc. has a 50% trademark registration rate, with 8 out of 16 resolved applications resulting in successful registration. Currently, 1 application is pending review.